InsiderTrades.com logo

AYTU Insider Trading

Insider Ownership Percentage: 4.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Aytu BioPharma Insider Trading History Chart

This chart shows the insider buying and selling history at Aytu BioPharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aytu BioPharma Share Price & Price History

Current Price: $2.20
Price Change: ▲ Price Increase of +0.03 (1.38%)
As of 09/29/2026 03:57 PM ET

This chart shows the closing price history over time for AYTU up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aytu BioPharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/28/2025Joshua R DisbrowCEOBuy15,000$1.30$19,500.0086,591View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Aytu BioPharma (NASDAQ:AYTU)

33.49% of Aytu BioPharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AYTU by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aytu BioPharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/19/2026Nantahala Capital Management LLC1,086,812$2.34M0.0%N/A10.129%Search for SEC Filing on Google Icon
8/18/2026Stonepine Capital Management LLC912,921$1.96M0.0%N/A8.508%Search for SEC Filing on Google Icon
8/15/2026AWM Investment Company Inc.619,574$1.33M0.1%N/A5.774%Search for SEC Filing on Google Icon
8/7/2026BlackRock Inc.22,793$49K0.0%N/A0.212%Search for SEC Filing on Google Icon
8/7/2026Crown Advisors Management Inc.200,000$0.43M0.2%N/A1.864%Search for SEC Filing on Google Icon
8/7/2026Persistent Asset Partners Ltd37,984$82K0.0%N/A0.354%Search for SEC Filing on Google Icon
5/20/2026Arete Wealth Advisors LLC49,549$0.14M0.0%N/A0.462%Search for SEC Filing on Google Icon
5/19/2026Arete Wealth Advisors LLC49,549$0.14M0.0%N/A0.462%Search for SEC Filing on Google Icon
5/7/2026Dimensional Fund Advisors LP43,585$0.12M0.0%+23.3%0.406%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd25,860$67K0.0%N/A0.241%Search for SEC Filing on Google Icon
2/17/2026Diadema Partners LP305,788$0.80M0.1%+12.1%2.850%Search for SEC Filing on Google Icon
2/17/2026Persistent Asset Partners Ltd79,415$0.21M0.1%+27.2%0.740%Search for SEC Filing on Google Icon
2/17/2026Rothschild Wealth LLC20,000$52K0.0%N/A0.186%Search for SEC Filing on Google Icon
2/12/2026DRW Securities LLC29,368$76K0.0%N/A0.274%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC89,623$0.23M0.0%-5.8%0.835%Search for SEC Filing on Google Icon
1/23/2026Bellevue Asset Management LLC25,013$65K0.0%N/A0.245%Search for SEC Filing on Google Icon
1/21/2026Daytona Street Capital LLC10,000$26K0.0%N/A0.098%Search for SEC Filing on Google Icon
1/16/2026FNY Investment Advisers LLC31,600$82K0.0%+24,207.7%0.310%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP68,736$0.13M0.0%+96.2%0.675%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP30,964$58K0.0%N/A0.304%Search for SEC Filing on Google Icon
11/10/2025Persistent Asset Partners Ltd62,452$0.12M0.1%N/A0.613%Search for SEC Filing on Google Icon
8/15/2025AWM Investment Company Inc.619,874$1.35M0.2%N/A6.903%Search for SEC Filing on Google Icon
8/13/2025Stonepine Capital Management LLC812,676$1.77M1.7%+75.3%9.053%Search for SEC Filing on Google Icon
7/30/2025FNY Investment Advisers LLC35,921$78K0.0%N/A0.400%Search for SEC Filing on Google Icon
7/15/2025Kanen Wealth Management LLC573,358$1.25M0.5%N/A6.385%Search for SEC Filing on Google Icon
5/15/2025Armistice Capital LLC57,597$69K0.0%-61.6%0.934%Search for SEC Filing on Google Icon
5/14/2025Stonepine Capital Management LLC463,721$0.56M0.5%+13.8%7.516%Search for SEC Filing on Google Icon
2/17/2025Stonepine Capital Management LLC407,549$0.69M0.6%-18.6%6.627%Search for SEC Filing on Google Icon
11/14/2024Stonepine Capital Management LLC500,958$1.18M0.7%+6.0%8.147%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC252,000$0.74M0.0%N/A4.220%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP23,551$69K0.0%+54.5%0.394%Search for SEC Filing on Google Icon
8/16/2023Stonepine Capital Management LLC472,369$0.76M0.3%N/A12.497%Search for SEC Filing on Google Icon
8/11/2023Stonepine Capital Management LLC472,369$0.76M0.3%N/A12.497%Search for SEC Filing on Google Icon
2/7/2023Commonwealth Equity Services LLC309,558$58K0.0%+47.7%9.922%Search for SEC Filing on Google Icon
11/4/2022Prudential Financial Inc.145,550$27K0.0%+257.2%0.233%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aytu BioPharma logo
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
Read More on Aytu BioPharma

Today's Range

Now: $2.20
Low: $2.16
High: $2.20

50 Day Range

MA: $2.22
Low: $1.97
High: $2.40

52 Week Range

Now: $2.20
Low: $1.67
High: $3.07

Volume

33,604 shs

Average Volume

50,040 shs

Market Capitalization

$23.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.26

Who are the company insiders with the largest holdings of Aytu BioPharma?

Aytu BioPharma's top insider investors include:
  1. Joshua R Disbrow (CEO)
  2. Greg Pyszczymuka (Insider)
  3. Armistice Capital Master Fund (Major Shareholder)
  4. Armistice Capital, Llc (Director)
  5. David A Green (CFO)
  6. Jarrett Disbrow (COO)
Learn More about top insider investors at Aytu BioPharma.

Aytu BioPharma Active Insiders

Joshua R Disbrow
Joshua R Disbrow (Age 51)
CEO